Transcutaneous Vagus Nerve Stimulation in Aphasia After Stroke

Recruiting N/A Interventional Study
Aphasia Chronic Stroke
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
36 (estimated)
Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Aphasia is an acquired language disorder. Stroke is the most common cause of aphasia, which affects 30% of stroke survivors. Speech and Language Therapy (SLT) can help people with aphasia but it may not be provided at the required intensity. Access to therapy is often limited after the first few months following stroke. People with aphasia can improve with therapy many years after stroke but these…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Supratentorial stroke at least 6 months prior to recruitment * Aphasia (with word finding difficulties) * Ability to engage in the programme (support can be provided for cognitive or receptive difficulties) * Sufficient vision to engage in the computer-based SLT programme Exc…
Contacts

Dr Ali Ali

01142159114

ali.ali@sheffield.ac.uk

CONTACT

Miss Samantha Dorney

sldorney1@sheffield.ac.uk

CONTACT